Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Copy Paste From - CEO.ca

<< Previous

Bullboard Posts

Next >>

Comment by askretkaon Jul 06, 2023 7:24pm

281 Views

Post# 35530090

RE:RE:RE:RE:RE:RE:Copy Paste From - CEO.ca

Sorry was just on my phone didn't have access to my ONC database on my computer. Gotta figure out how to get that linked to the cloud or something. " Cancer Treatment Goes Viral."

Around the 32.10 minute mark."

"2nd line Pancreatic cancer patients

is not a market you'd really want to persue because it is such a difficult disease to treat."

https://open.spotify.com/episode/6oiRTt0u71Qxjjm19xGq0H?si=YTsQw_hHRL2W_ogLSIWCCw

We held up today pretty good in a tough market. Oncolytic Biotech searches are up in Germany last 7 days. Might be significant, maybe not?

CHEERS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it